No evidence of activated blood coagulation in Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 10, 1997, Pages 963-967

  Novacek, Gottfried ^a   Kapiotis, Stylianos ^a   Moser, Gabriele ^a   Speiser, Wolfgang ^a   Gangl, Alfred ^a   Vogelsang, Harald ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blood coagulation; C reactive protein; Crohn's disease; Fibrinogen; Orosomucoid; Pathogenesis; Thrombin antithrombin III complex; Thromboembolism

Indexed keywords

ANTITHROMBIN III; C REACTIVE PROTEIN; FIBRINOGEN; OROSOMUCOID; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CEREBELLUM INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

EID: 0030864544     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199710000-00008     Document Type: Article

References (38)

1. Bargen JA, Barker NW: Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936, 58:17-31.
2. Sloan WP, Barger JA, Gage RP: Life histories of patients with chronic ulcerative colitis: a review of 2000 cases. Gastroenterology 1950, 16:25-38.
3. Graef V, Baggenstors AH, Sauer WG, et al.: Venous thrombosis occurring in non-specific ulcerative colitis. A necropsy study. Arch Intern Med 1966, 117:377-382.
4. Edwards FC, Truelove SC: The course and prognosis of ulcerative colitis. III. Complications. Gut 1964, 5;1-22.
5. Talbot RW, Hepell J, Dozois RR, et al.: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986, 61:140-145.
6. Wakefield AJ, Sawyerr AM, Dhillon AP, et al.: Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989, ii:1057-1062.
7. Wakefield AJ, Sankey EA, Dhillon AP, et al.: Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991, 100:1279-1287.
8. Sankey EA, Dhillon AP, Anthony A, et al.: Early mucosal changes in Crohn's disease. Gut 1993, 34:375-381.
9. Ghosh S, Mackie MJ, McVerry BA, et al.: Chronic inflammatory bowel disease, deep venous thrombosis and AT activity. Acta Haematol 1983, 70:50-53.
10. Edwards RL, Levine JB, Green R, et al.: Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A and enhanced generation of monocyte tissue factor activity. Gastroenterology 1987, 92:329-337.
11. De Jong E, Porte RJ, Knot EA, et al.: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa and faeces. Gut 1989, 30:188-194.
12. Van Wersch JW, Houben P, Rijken J: Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem 1990, 28:513-517.
13. Hudson M, Hutton RA, Wakefield AJ, et al.: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 1992, 3:773-778.
14. Stevens TR, James JP, Simmonds NJ, et al.: Circulating von Willebrand factor in inflammatory bowel disease. Gut 1992, 33:502-506.
15. Hudson M, Wakefield AJ, Hutton RA, et al.: Factor XIIIa subunit and Crohn's disease. Gut 1993, 34:75-79.
16. Aadland E, Odegaard OR, Roseth A, et al.: Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol 1994, 29:333-335.
17. Morowitz DA, Allen LW, Kirsner JB: Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 1968, 68:1013-1021.
18. Simi M, Leardi S, Tebano MT, et al.: Raised plasma concentrations of platelet factor 4 (PF 4) in Crohn's disease. Gut 1987, 28:336-338.
19. Webberley MJ, Hart MT, Melikian V: Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993, 34:247-251.
20. Collins CE, Cahill MR, Newland AC, et al.: Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994, 106:840-845.
21. Novacek G, Vogelsang H, Genser D, et al.: Changes in blood rheology caused by Crohn's disease. Eur J Gastroenterol Hepatol 1996, 8:1089-1093.
22. Hudson M, Chitolie A, Hutton RA, et al.: Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996, 38:733-737.
23. Blanke H, Praetorius G, Leschke M, et al.: Diagnostic value of thrombin-antithrombin III complex in pulmonary embolism and in deep vein thrombosis - comparison with fibrinopeptide A, platelet factor 4, and beta-thromboglobulin. Klin Wochenschr 1987, 65:757-763.
24. Speiser W, Mallek R, Koppensteiner R, et al.: D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemost 1990, 64:196-201.
25. Takahashi H, Tatewaki W, Wada K, et al.: Thrombin versus plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990, 33:90-95.
26. Chamouard P, Grunebaum L, Wiesel ML, et al.: Prothrombin fragment 1+2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995, 7:1183-1188.
27. Souto JC, Martinez E, Roca M, et al.: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995, 40:1883-1889.
28. Smith CJ, Haire WD, Kaufman SS, et al.: Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol 1996, 91:1221-1225.
29. Best WR, Becktel JM, Singelton JW, et al.: Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
30. Malchow H, Ewe K, Brandes JW, et al.: European cooperative Crohn's disease study (ECCDS): Results of drug treatment. Gastroenterology 1984, 86:249-266.
31. Andre C, Descos L, Landais P, et al.: Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981, 22:571-574.
32. Hollander M, Wolfe D: Nonparametric Statistical Methods. New York: John Wiley & Sons; 1973.
33. Meade TW, Vickers MV, Thompson SG, et al.: The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 1985, 38:527-534.
34. Lowe GDO, Drummond MM, Lorimer AR, et al.: Relation between extent of coronary artery disease and blood viscosity. BMJ 1980, 1:673-674.
35. Cristal N, Slomin A, Bar-Ilan I, et al.: Plasma fibrinogen levels and clinical course of acute myocardial infarction. Angiology 1983, 34:693-698.
36. Harenberg J. Thrombin-antithrombin III complexes. In ECAT (European Concerted Action on Thrombosis and Disabilities of the Commission of the European Communities) Assay Procedures. A Manual of Laboratory Techniques. Edited by Jespersen J, Bertina RM, Haverkate F. Dordrecht, Boston, London: Kluwer Academic Publishers; 1992: 117-123.
37. Cofrancesco E, Cortellaro M, Corradi A, et al.: Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery. Thromb Haemost 1997, 77: 267-269.
38. Nick PT, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995, 108:1011-1015.